Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$1.39 - $3.19 $152,622 - $350,262
-109,800 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$1.96 - $2.81 $215,208 - $308,538
109,800 New
109,800 $283,000
Q3 2019

Nov 13, 2019

SELL
$2.12 - $9.37 $106,000 - $468,499
-50,000 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$6.27 - $9.48 $313,500 - $474,000
50,000 New
50,000 $455,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.